G8569#
Prolonged intubation (>24 hrs) required
G8570#
Prolonged intubation (>24 hrs) not required
G8571#
Development of deep sternal wound infection within 30 days postoperatively
G8572#
No deep sternal wound infection
G8573#
Stroke/CBA following isolated CABG surgery
G8574#
No stroke/CVA following isolated CABG surgery
G8575#
Developed postoperative renal insufficiency or required dialysis
G8576#
No postoperative renal insufficiency/dialysis not required
G8577#
Reoperation required due to bleeding/tamponade, graft occlusion or other cardiac reason
G8578#
Reoperation not required due to bleeding/tamponade, graft occlusion or other cardiac reason
G8579#
Antiplatelet medication at discharge
G8580#
Antiplatelet medication contraindicated/not indicated
G8581#
No antiplatelet medication at discharge
G8582#
Beta-blocker at discharge
G8583#
Beta-blocker contraindicated/not indicated
G8584#
No beta-blocker at discharge
G8585#
Anti-lipid treatment at discharge
G8586#
Anti-lipid treatment contraindicated/not indicated
G8587#
No anti-lipid treatment at discharge
G8588#
Most recent systolic blood pressure < 140 mmhg
G8589#
Most recent systolic blood pressure >= 140 mmhg
G8590#
Most recent diastolic blood pressure < 90 mmhg
G8591#
Most recent diastolic blood pressure >= 90 mmhg
G8592#
No documentation of blood pressure measurement
G8593#
Lipid profile results documented and reviewed (must include total cholesterol, HDL-C, triglycerides and calculated LCD-C)
G8594#
Lipid profile not performed, reason not otherwise specified
G8595#
Most recent LCD-C < 100 mg/dl
G8596#
LCD-C was not performed
G8597#
Most recent LCL-C >= 100 mg/dl
G8598#
Aspirin or another antithrombotic therapy used
G8599#
Aspirin or another antithrombotic therapy not used, reason not otherwise specified
G8600#
LV T-PA initiated within three hours (<= 180 minutes) of time last known well
G8601#
LV T-PA not initiated within three hours (<= 180 minutes) of time last known well for reasons documented by clinician
G8602#
LV T-PA not initiated within three hours (<= 180 minutes) of time last known well, reason not specified
G8603#
Score on the spoken language comprehension functional communication measure at discharge was higher than at admission
G8604#
Score on the spoken language comprehension functional communication measure at discharge was not higher than at admission, reason not specified
G8605#
Patient was not scored on the spoken language comprehension functional communication measure either at admission or at discharge
G8606#
Score on the attention functional communication measure at discharge was higher than at admission
G8607#
Score on the attention functional communication measure at discharge was not higher than at admission, reason not specified
G8608#
Patient was not scored on the attention functional communication measure either at admission or at discharge
G8609#
Score on the memory functional communication measure at discharge was higher than at admission
G8610#
Score on the memory functional communication measure at discharge was not higher than at admission, reason not specified
G8611#
Patient was not scored on the memory functional communication measure at either admission or at discharge
G8612#
Score on the motor speech functional communication measure at discharge was higher than at admission
G8613#
Score on the motor speech functional communication measure at discharge was not higher than at admission, reason not specified
G8614#
Patient was not scored on the motor speech functional communication measure either at admission or at discharge
G8615#
Score on the reading functional communication measure at discharge was higher than at admission
G8616#
Score on the reading functional communication measure at discharge was not higher than at admission, reason not specified
G8617#
Patient was not scored on the reading functional communication measure either at admission or at discharge
G8618#
Score on the spoken language expression functional communication measure at discharge was higher than at admission
G8619#
Score on the spoken language expression functional communication measure at discharge was not higher than at admission, reason not specified
G8620#
Patient was not scored on the spoken language expression functional communication measure either at admission or at discharge
G8621#
Score on the writing functional communication measure at discharge was higher than at admission
G8622#
Score on the writing functional communication measure at discharge was not higher than at admission, reason not specified
G8623#
Patient was not scored on the writing functional communication measure either at admission or at discharge
G8624#
Score on the swallowing functional communication measure at discharge was higher than at admission
G8625#
Score on the swallowing functional communication measure at discharge was not higher than at admission, reason not specified
G8626#
Patient was not scored on the swallowing functional communication measure at admission or at discharge
G8627#
Surgical procedure performed within 30 days following cataract surgery for major complications (e.g., retained nuclear fragments, endophthalmitis, dislocated or wrong power IOL, retinal detachment, or wound dehiscence)
G8628#
Surgical procedure not performed within 30 days following cataract surgery for major complications (e.g., retained nuclear fragments, endophthalmitis, dislocated or wrong power IOL, retinal detachment, or wound dehiscence)
J0461
Injection, atropine sulfate, 0.01 mg
J0559
Injection, penicillin G benzathine and penicillin G procaine, 2,500 units
J0586
Injection, abobotulinumtoxina, 5 units
J0598
Injection, C1 esterase inhibitor (human), 10 units
J0718#
Injection, certolizumab pegol, 1 mg
J0833
Injection, cosyntropin, not otherwise specified, 0.25 mg
J0834
Injection, cosyntropin (cortrosyn), 0.25 mg
J1680
Injection, human fibrinogen concentrate, 100 mg
J2562
Injection, plerixafor, 1 mg
J2793
Injection, rilonacept, 1 mg
J2796
Injection, romiplostim, 10 micrograms
J7185
Injection, factor VIII (antihemophilic factor, recombinant) (xyntha), per i.u.
J7325
Hyaluronan or derivative, synvisc or synvisc-one, for intra-articular injection, 1 mg
J9155
Injection, degarelix, 1 mg
J9171
Injection, docetaxel, 1 mg
J9328
Injection, temozolomide, 1 mg
L2861#
Addition to lower extremity joint, knee or ankle, concentric adjustable torsion style mechanism for custom fabricated orthotics only, each
L3891#
Addition to upper extremity joint, wrist or elbow, concentric adjustable torsion style mechanism for custom fabricated orthotics only, each
L5973
Endoskeletal ankle foot system, microprocessor controlled feature, dorsiflexion and/or plantar flexion control, includes power source
L8031
Breast prosthesis, silicone or equal, with integral adhesive
L8032
Ripple prosthesis, reusable, any type, each
L8627
Cochlear implant, external speech processor, component, replacement
L8628
Cochlear implant, external controller component, replacement
L8629
Transmitting coil and cable, integrated, for use with cochlear implant device, replacement
L8692#
Auditory osseointegrated device, external sound processor, used without osseointegration, body worn, includes headband or other means of external attachment
Q0138
Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-ESRD use)
Q0139
Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (for ESRD on dialysis)
Q0506
Battery, lithium-ion, for use with electric or electric/pneumatic ventricular assist device, replacement only
Q4074#
Iloprost, inhalation solution, FDA-approved final product, non-compounded, administered through DME, unit dose form, up to 20 micrograms
Q9968
Injection, non-radioactive, non-contrast, visualization adjunct (e.g., methylene blue, isosulfan blue), 1 mg
# Not payable codes
